Dados B3 › GOAU4 × SUZB3
GOAU4 × SUZB3
Indicators
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | GOAU4 | SUZB3 | year |
|---|---|---|---|
| ROE | 2.4% | 35.2% | 2025 |
| ROIC | 3.3% | 6.2% | 2025 |
| ROA | 1.7% | 8.0% | 2025 |
| Gross margin | 11.4% | 32.4% | 2025 |
| EBIT margin | 5.3% | 21.2% | 2025 |
| Net margin | 2.0% | 26.8% | 2025 |
| Net debt/EBITDA | 1.05x | 3.18x | 2025 |
| Current ratio | 2.90x | 3.19x | 2025 |
| Revenue growth (1y) | 4.2% | 5.7% | 2025 |
| Revenue growth (5y CAGR) | 9.8% | 10.5% | 2025 |
| Piotroski F-Score | 4/9 | 8/9 | 2025 |
Point-in-time multiples
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | GOAU4 | SUZB3 | year |
|---|---|---|---|
| P/E | 27.08x | 4.71x | 2025 |
| P/B | 0.67x | 1.44x | 2025 |
| EV/EBITDA | 2.79x | 6.05x | 2025 |
| FCF yield | 8.8% | 21.4% | 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-09 12:37 UTC. If this does not match /saude, you are reading a cached copy.
Sources: CVM (open data, ODbL) and B3 (COTAHIST). Not affiliated with B3 or the CVM. Not investment advice.